< Back to scientific publications

Magazine

Use of Plerixafor in Predicted and ProvenPoorMobilizer( according to GITMO criteria). Experience of Tor Vergata University Polyclinic.

Authors: Massimiliano Postorino, Alessandro Lanti, Eleonora Florelli, Angelo Salvatore Ferraro, Oana Marilena Chiuru,Raffaella Massarelli, Luca Franceschini, Giorgia Guiducci,Provenzano I., Livio Pupo, Anna Giulia Zizzari, GaspareAdorno, Maria Cantonetti, Giancarlo Isacchi and Sergio Amadori. (2012).

Date: 2012

Scope of interest: Hematology/Transfusion Medicine




You may also be interested in:

Report/Poster of Convention/Congress Act

Sars -cov 2 epidemiology , therapy ,prevention

Authors: ilaria uccella

Date: 2020

Scope of interest: infectious disease training programs


Read details
Magazine 5.8

Feasibility and efficacy of 8 week Glecaprevir/Pibrentasvir to treat incarcerated viraemic HCV patients: A case-control study.

Authors: Flower v

Date: 21 Feb 2023

Scope of interest: infectious diseases/penitentiary health


Read details
Report/Poster of Convention/Congress Act

ORAL COMMUNICATION European project “AIDS and Mobility 2008-2011

Authors: ilaria uccella

Date: 2012

Scope of interest: infectious disease training programs


Read details